Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Cellular Origins and Cytiva are collaborating to deliver automated robotic manufacturing capabilities for cell and gene therapies

    Jan 17, 2025, 06:59 AM by
    Full story
  • Avalon Healthcare Solutions to Team with Sentara Health Plans to Offer Genetic Testing Management

    Jan 16, 2025, 08:11 AM by
    Avalon Healthcare Solutions to Team with Sentara Health Plans to Offer Genetic Testing Management
    Full story
  • Cotiviti Launches Engagement Hub Solution to Empower Health Plans to Drive Member Outreach

    Jan 16, 2025, 08:11 AM by
    Full story
  • Ambience Healthcare and St. Luke's Health System Partner to Reduce Clinician Burnout and Increase Patient Face Time

    Jan 16, 2025, 08:11 AM by
    Ambience Healthcare, the leading AI platform for healthcare documentation, scribing, coding, CDI, and patient summaries, announced today a pilot study with St. Luke's Health System has resulted in a 25% reduction in clinician burnout and a nearly 23% increase in patient face time for clinicians.
    Full story
  • Illumina at JPM: Multi-Omics, Constellation, Partnerships

    Jan 16, 2025, 01:00 AM by User Not Found
    Bio-IT World | Jacob Thaysen gave Illumina’s annual presentation at the 43rd Annual J.P. Morgan Healthcare Conference yesterday, outlining Illumina’s early 2024 results and the vision for the future. Illumina is not focusing only on building sequencers and sequencing genomes. Thaysen outlined an M&A and partnership strategy focused on expanding the company’s addressable markets.
    Full story
  • University Medical Centre Ljubljana and University Hospital of Maribor Elevate Antimicrobial Stewardship with DoseMeRx

    Jan 15, 2025, 08:41 AM by
    DoseMe, a leader in model-informed precision dosing (MIPD), announced the University Medical Centre Ljubljana and University Hospital of Maribor have implemented DoseMeRx, an innovative therapeutic drug monitoring (TDM) platform. This marks a significant advancement in antimicrobial stewardship in Slovenia.
    Full story
  • Oxford Nanopore at JPM: A Proteomics-Genomics Thing of Beauty

    Jan 15, 2025, 01:00 AM by User Not Found
    Bio-IT World | Gordon Sanghera, CEO, presented on behalf of Oxford Nanopore Technologies at the 43rd Annual J.P. Morgan Healthcare Conference this week in San Francisco. Sanghera led the major sequencing companies in position on the program, presenting on Monday a multi-omics and proteomics emphasis that was echoed throughout the week by other sequencing platform providers.
    Full story
  • Integrated DNA Technologies Names Ajay Gannerkote as New President to Lead Bold Era of Innovation and Growth

    Jan 14, 2025, 08:17 AM by
    Ajay Gannerkote, an experienced healthcare leader with more than 20 years of demonstrated success driving industry growth and transformation, takes helm at global genomics company
    Full story
  • Proscia’s Growth More Than Doubles As Customers Adopt Enterprise Pathology

    Jan 14, 2025, 08:17 AM by
    Record year comes as the rise of precision medicine drives a surge in demand
    Full story
  • Exploring Muscle Clues in Chronic Fatigue Syndrome and Long COVID

    Jan 14, 2025, 01:00 AM by User Not Found
    Bio-IT World | An international team of researchers is delving into the molecular and cellular changes in muscle tissue associated with Chronic Fatigue Syndrome (CFS) and long COVID. The effort focuses on identifying biomarkers and pathways that could pave the way for diagnosis and treatment.
    Full story
  • Illumina Joins NVIDIA’s Agentic AI Vision at J.P. Morgan Healthcare Conference

    Jan 13, 2025, 09:00 AM by User Not Found
    Bio-IT World | Among the many partnerships and technical announcements made by NVIDIA during the company's Monday morning presentation at the 43rd Annual J.P. Morgan Healthcare Conference, NVIDIA focused several on innovation within the healthcare and life sciences industry.
    Full story
  • Absci and Owkin Synergize Leading TechBio Platforms to Advance Generative AI Drug Discovery

    Jan 13, 2025, 08:15 AM by
    Collaboration combines Owkin’s novel AI target discovery and agentic AI expertise with Absci’s leading AI de novo design models to accelerate the discovery and design of potential first-in-class therapeutics
    Full story
  • Chromatin Bioscience’s synthetic promoter supports EsoBiotec’s ESO-T01 CAR-T therapy as it enters the clinic

    Jan 13, 2025, 08:15 AM by
    Chromatin Bioscience is pleased to announce its ongoing collaboration with EsoBiotec, which has successfully advanced its ESO-T01 in vivo CAR-T candidate into clinical trials. ESO-T01 is the first in vivo B-cell maturation antigen (BCMA) CAR-T candidate to reach the clinical stage and utilises a synthetic promoter designed using Chromatin Bio’s proprietary promoter design platform, chromatinLENS, exclusively for EsoBiotec as part of its innovative approach to immunotherapy.
    Full story
  • STEMart Announces Balloon Catheter Testing Services to Ensure Medical Device Safety and Regulatory Compliance

    Jan 10, 2025, 08:28 AM by
    STEMart introduces Balloon Catheter Testing Services for the development of safe and effective medical devices.
    Full story
  • Biofidelity and CellCarta partner to deploy Aspyre® Lung in global clinical trials

    Jan 10, 2025, 08:28 AM by
    Biofidelity and CellCarta have announced a strategic partnership agreement to utilize Biofidelity’s Aspyre® Lung in global clinical trials.
    Full story
  • Kindeva Drug Delivery and Emervax Partner To Bring Game Changing Vaccine Administration to Patients

    Jan 10, 2025, 08:28 AM by
    Full story
  • Coronado Research announce appointment of Jo Marshall as EVP Data Services and Advanced Analytics

    Jan 10, 2025, 08:28 AM by
    Coronado Research is pleased to announce the appointment of Jo Marshall as EVP of Data Services and Advanced Analytics.
    Full story
  • ThirdLaw Molecular Inc. Launches its Groundbreaking Platform for Targeted Drug Discovery with a 4.5-Billion Molecule DNA-Encoded Library of Spiroligomer™ Macromolecules

    Jan 9, 2025, 08:35 AM by
    ThirdLaw Molecular Inc., a targeted drug discovery biotech reimagining molecular therapeutics, today announced the launch of its first DNA-encoded library of 4.5 billion Spiroligomer™ macromolecules. This library provides the Company and prospective partners access to a revolutionary category of molecules and the potential to transform how diseases are diagnosed and treated
    Full story
  • From Generative AI and ML to Quantum Computing, Bio-IT World 2025 Showcases Technologies Poised to Accelerate Lifesaving Therapies

    Jan 9, 2025, 08:35 AM by
    Bio-IT World Conference & Expo, the premier annual gathering of 3,000 innovators at the intersection of IT and life sciences, returns to Boston April 2-4, ready to meet participants’ demand for the latest information on cutting-edge technologies like generative AI, machine learning (ML), and quantum computing that promise to shape precision medicine and redefine patient outcomes.
    Full story
  • Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform

    Jan 9, 2025, 08:35 AM by
    Leica Biosystems and Indica Labs today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs.
    Full story
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17 (current)
  • 18
  • 19
  • 20
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy